000			01768 a2200469 4500
005			20250513130420.0
264		0	_c19971113
008			199711s 0 0 eng d
022			_a0093-7754
040			_aNLM _beng _cNLM
100	1		_aMotzer, R J
245	0	0	_aPaclitaxel in salvage therapy for germ cell tumors. _h[electronic resource]
260			_bSeminars in oncology _cOct 1997
300			_aS15-83-S15-85 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Agents, Alkylating _xadministration & dosage
650	0	4	_aAntineoplastic Agents, Phytogenic _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aArea Under Curve
650	0	4	_aBlood Cells _xdrug effects
650	0	4	_aCarboplatin _xadministration & dosage
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aCohort Studies
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aEtoposide _xadministration & dosage
650	0	4	_aFollow-Up Studies
650	0	4	_aGerminoma _xdrug therapy
650	0	4	_aHumans
650	0	4	_aIfosfamide _xadministration & dosage
650	0	4	_aMale
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aPrognosis
650	0	4	_aRemission Induction
650	0	4	_aSalvage Therapy
650	0	4	_aStem Cell Transplantation
650	0	4	_aTesticular Neoplasms _xdrug therapy
650	0	4	_aTreatment Outcome
773	0		_tSeminars in oncology _gvol. 24 _gno. 5 Suppl 15 _gp. S15-83-S15-85
999			_c9317044 _d9317044